Portal Hypertension
Abraham Levitin, MD
Staff
The Cleveland Clinic Foundation
Nancy Obuchowski, PhD
Staff
Cleveland Clinic
Karunakaravel Karuppasamy, MD
Staff
Cleveland Clinic
Sameer Gadani, MD FSIR
Staff
Cleveland Clinic Foundation
To study the safety, technical and short-term clinical success, patency of the TIPS, and factors leading to reintervention (RI) and re-thrombosis.
Materials and Methods:
This is an IRB-approved retrospective study of 25 pts who underwent TIPS between (8/19-10/22) for acute or chronic portal/splanchnic vein (SV) thrombosis leading to their partial or complete occlusion with refractory portal hypertension complications or listed for liver transplantation. Reviewed outcomes include technical success, complications, TIPS/PV/SV patency, and clinical success. Variables studied include involvement of venous confluence, SV occlusion, Yerdel grade, embolization of varix during the procedure, TIPS size & port-systemic gradient (PSG). Considering the small sample size, univariate logistic regression was used to test each predictor separately. A significance level of 0.05 was applied.
Results:
Table 1 for patient characteristics. Procedures were performed by 3 IR physicians. No significant predictors were found for occlusion (very small number). PSG has a significant and nonlinear effect on RI rate. Table 2 for results and Table 3 for analysis.
Conclusion:
With careful patient selection, high technical & clinical success with prolonged patency of the TIPS for advanced acute & chronic PV & SV thrombosis can be achieved with minimal morbidity. In our review, a nonlinear correlation was found between PSG and RI.